Myeloproliferative Neoplasms Clinical Trial
Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia
Summary
The objective of this study is to test the scale structure, reliability, validity and responsiveness to change of the QLQ-leukemia-cml/" >CML24 in conjuction with the QLQ-C30 for patients diagnosed with CML, and to investigate longitudinal relationship between satisfaction with information provision and QoL outcomes.
Eligibility Criteria
Inclusion Criteria:
Above 18 years of age.
Patient with confirmed diagnosis of Philadelphia chromosome positive and/or BCR-ABL positive chronic myeloid leukemia (CML).
Written informed consent.
Patients enrolled in investigational drug-trials or other type of clinical trials are also eligible.
Exclusion Criteria:
Patients with a psychiatric condition or major cognitive impairment (as evaluated by their treating physician) that would hinder completion of self-reported health-related QoL questionnaires.
Patients who are unable to speak and read the language of the questionnaire.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 4 Locations for this study
Emory Georgia, 30322, United States
Innsbruck , , Austria
Paranã , , Brazil
Guangdong , , China
Heidelberg , , Germany
Baghdad , , Iraq
Ancona , , Italy
Bari , , Italy
Bologna , , Italy
Brescia , 21125, Italy
Cagliari , , Italy
Catania , , Italy
Genova , , Italy
Lecce , , Italy
Milano , , Italy
Novara , , Italy
Palermo , , Italy
Parma , , Italy
Pavia , 27100, Italy
Piacenza , , Italy
Ravenna , , Italy
Reggio Emilia , , Italy
Roma , , Italy
Roma , , Italy
Roma , , Italy
Roma , , Italy
San Giovanni Rotondo , , Italy
Sassari , , Italy
Verona , , Italy
Vicenza , 36100, Italy
Kuala Lumpur , , Malaysia
Eindhoven , , Netherlands
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.